◆ Market Data --:--
Commodities
Loading...
📈 Yields & Rates
Loading...
💱 FX Rates
Loading...
📈 Market Pulse
Loading...
🏛 Congress Trades
Loading...
👤 Insider Trades
Loading...
Customize Items

Enveric Biosciences, Inc.

CIK: 890821 SIC: 2834
-
Revenue
$-8.77M
Net Income
-
Gross Margin
-
Op. Margin
$-14.81M
Free Cash Flow
Financial Statements Annual (10-K)
Showing 10 of 11 annual reports available (2011 - 2025)
Breakdown TTM
(Dec 31, 2025)
FY 2025
(Dec 31, 2025)
FY 2024
(Dec 31, 2024)
FY 2023
(Dec 31, 2023)
FY 2021
(Dec 31, 2021)
FY 2020
(Dec 31, 2020)
FY 2018
(Dec 31, 2018)
FY 2017
(Dec 31, 2017)
FY 2014
(Dec 31, 2014)
FY 2013
(Dec 31, 2013)
FY 2012
(Dec 31, 2012)
+ Total Revenue - - - - - - $43.00M $48.59M - - -
Revenue Growth % nan% nan% nan% nan% nan% nan% -11.5% nan% nan% nan% nan%
Cost of Revenue - - - - - - $34.01M $38.36M - - -
+ Gross Profit - - - - - - $8.98M $10.24M - - -
Gross Margin % nan% nan% nan% nan% nan% nan% 20.9% 21.1% nan% nan% nan%
Operating Expenses - - - - - - $16.13M $22.21M - - -
Research & Development $2.78M $2.78M $2.84M $7.25M $4.79M $174.08K - - - - -
Selling General & Admin - - - - $20.50M $5.44M $10.79M $18.51M - - -
+ Operating Income $-8.77M $-8.77M $-9.63M $-16.45M $-64.62M $-5.62M $-7.15M $-11.97M $32.81K $27.21K $-22.69K
Operating Margin % nan% nan% nan% nan% nan% nan% -16.6% -24.6% nan% nan% nan%
Interest Expense - - - - $10.32K $445.25K $729.90K $575.04K - - -
Other Income/Expense - $2.46K $66.21K $-814.38K $8.19M $1.25M $-3.40M $504.11K - - -
Income Before Tax $-8.77M $-8.77M $-9.57M $-17.26M $-56.43M $-6.86M $-10.55M $-11.47M $-32.81K $1.29K $-22.69K
Income Tax Expense - - $8.93K $28.91K $-7.45M - $6.35M $-2.39M $833.00 $1.45K $1.93K
+ Net Income $-8.77M $-8.77M $-9.57M $-17.29M $-48.98M $-6.86M $-16.90M $-9.07M $-33.64K $-161.00 $-24.62K
Net Margin % nan% nan% nan% nan% nan% nan% -39.3% -18.7% nan% nan% nan%
Basic EPS nan -36.24 -19.04 -8.09 nan nan -0.82 -0.75 nan nan nan
Diluted EPS nan -36.24 -19.04 -8.09 nan nan -0.82 -0.75 nan nan nan
Basic Shares Outstanding 108K 335K 42K 2.2M - 5.8M 23.8M 15.0M 15.2M 12.1M 12.1M
Diluted Shares Outstanding 108K 335K 42K 2.2M - - 23.8M 15.0M - - -
Breakdown FY 2025
(Dec 31, 2025)
FY 2024
(Dec 31, 2024)
FY 2023
(Dec 31, 2023)
FY 2021
(Dec 31, 2021)
FY 2020
(Dec 31, 2020)
FY 2018
(Dec 31, 2018)
FY 2017
(Dec 31, 2017)
FY 2014
(Dec 31, 2014)
FY 2013
(Dec 31, 2013)
FY 2012
(Dec 31, 2012)
Cash & Cash Equivalents $4.68M $2.24M $2.29M $17.36M $1.58M $1.37M $4.88M $5.08K $249.00 $1.38K
Accounts Receivable - - - - - $7.87M $8.84M - - -
Other Current Assets $259.22K $493.56K $1.29M $380.84K $700.71K $818.60K $924.27K - $4.22K $4.22K
Total Current Assets $4.94M $2.73M $3.58M $17.74M $2.28M $10.06M $14.64M $5.08K $4.47K $5.60K
Property Plant & Equipment $159.23K $305.78K $507.38K $294.43K - $58.89K $95.05K - - -
Goodwill - - - $1.59M - $13.73M $21.90M - - -
Intangible Assets - $42.18K $210.93K $6.92M $1.82M $5.78M $9.47M - - -
Total Assets $5.10M $3.08M $4.30M $26.72M $4.10M $29.64M $52.20M $5.08K $4.47K $5.60K
Accounts Payable $581.02K $521.75K $1.22M - - $4.38M $5.32M - - -
Accrued Liabilities $237.50K $735.10K $1.08M $1.29M - - - - - -
Other Current Liabilities $99.88K $232.89K $23.61K - - - - - - -
Total Current Liabilities $918.40K $1.49M $2.34M $2.08M $681.25K $14.69M $30.37M $8.96K $24.70K $25.67K
Long-term Debt - - - - - - $1.13M - - -
Total Liabilities - - - $4.41M $681.25K $18.88M $32.75M - - -
Common Stock $10.62K $565.00 $27.39K $325.79K $100.95K $423.29K $181.62K $171.42K $121.42K $121.42K
Retained Earnings $-114.85M $-106.07M $-96.50M $-60.74M $-11.76M $-34.48M $-15.00M $-47.43M $-47.39M $-47.39M
Total Stockholders Equity $4.18M $1.59M $1.96M $22.31M $3.42M $-65.45K $19.45M $-3.87K $-20.23K $-20.07K
Total Liabilities & Equity $5.10M $3.08M $4.30M $26.72M $4.10M $29.64M $52.20M $5.08K $4.47K $5.60K
Breakdown TTM
(Dec 31, 2025)
FY 2025
(Dec 31, 2025)
FY 2024
(Dec 31, 2024)
FY 2023
(Dec 31, 2023)
FY 2021
(Dec 31, 2021)
FY 2020
(Dec 31, 2020)
FY 2018
(Dec 31, 2018)
FY 2017
(Dec 31, 2017)
FY 2014
(Dec 31, 2014)
FY 2013
(Dec 31, 2013)
FY 2012
(Dec 31, 2012)
Net Income $-10.96M $-8.77M $-9.57M $-17.29M $-48.98M $-6.86M $-16.90M $-9.07M $-33.64K $-161.00 $-24.62K
Depreciation & Amortization $200.86K $200.86K $337.49K $343.98K $656.64K $120.87K $2.90M $3.22M - - -
Stock-based Compensation $1.42M $827.32K $1.56M $2.15M - $1.98M - $7.08M - - -
Deferred Income Tax - - - - - - - $-2.39M - - -
Change in Receivables - - - - - - $-967.03K $778.54K - - -
Operating Cash Flow $-14.81M $-8.14M $-7.73M $-14.09M $-11.46M $-3.89M $-2.57M $-2.74M $-43.16K $-21.63K $-24.85K
Capital Expenditure - - - $5.18K - - - - - - -
Acquisitions - - - - - - $3.65M $804.04K - - -
Investing Cash Flow - - - $11.67K $2.19M $-44.14K $-3.64M $-808.88K - - -
Stock Issued - - $2.29M - $21.61M $488.00K $6.33M $4.90M $50.00K $100.00K -
Financing Cash Flow $19.93M $10.58M $7.67M $-1.34M $24.90M $5.53M $2.69M $7.05M $48.00K $20.50K $8.00K
Net Change in Cash $5.10M $2.44M $-46.95K $-15.44M $15.78M $1.53M $-3.51M $3.50M $1.38K $-1.13K $-16.85K
SEC Filing Format - Data shown as it appears in the Q3 2025 (10-Q) filing Period ended: Sep 30, 2025
Condensed Consolidated Statements of Operations
Description Sep 30, 2025 Sep 30, 2025
Current Prior Year Current YTD Prior Year YTD
Research & Development $402.42K - $2.41M -
Operating Income $-1.87M - $-6.58M -
Interest Expense - - - -
Other Income/Expense - - $2.56K -
Income Before Tax $-1.87M - $-6.58M -
Income Tax Expense - - - -
Net Income $-1.87M $-1.88M $-6.58M -
Basic EPS -10.81 - -35.74 -
Diluted EPS -10.81 - -35.74 -
Basic Shares Outstanding $313.24K - $226.40K -
Diluted Shares Outstanding $313.24K - $226.40K -
Condensed Consolidated Balance Sheets
Description Sep 30, 2025 Dec 31, 2024
Cash & Cash Equivalents $3.76M $2.24M
Other Current Assets $407.95K $493.56K
Total Current Assets $4.17M $2.73M
Property Plant & Equipment $196.52K $305.78K
Intangible Assets - $42.18K
Total Assets $4.36M $3.08M
Accounts Payable $683.71K $521.75K
Other Current Liabilities - $232.89K
Total Current Liabilities $905.88K $1.49M
Common Stock $5.18K $565.00
Retained Earnings $-112.65M $-106.07M
Total Stockholders Equity $3.46M $1.59M
Total Liabilities & Equity $4.36M $3.08M
Condensed Consolidated Statements of Cash Flows
Description Sep 30, 2025 Sep 30, 2025
Current Prior Year Current YTD Prior Year YTD
Net Income $-1.87M $-1.88M $-6.58M -
Depreciation & Amortization $40.37K - $161.37K -
Stock-based Compensation - - $587.09K -
Operating Cash Flow - - $-6.36M -
Stock Issued - - - -
Financing Cash Flow - - $7.89M -
Net Change in Cash - - $1.52M -

All values are in USD (United States Dollars). Data is sourced from SEC EDGAR 10-K filings.

Annual data represents full fiscal year results. FY = Fiscal Year ending.

NEWS
Loading article...
NEWS
Loading news...
TRENDING
Loading...